2023-10-25 04:00:59
Currently it is estimated that around 12.4 million people in Mexico suffer from diabetes.
The Clinical Practice Guide for the care of type 2 diabetes was published by the Mexican Journal of Endocrinology, Metabolism and Nutrition.
Its objective is to reduce the gap between scientific knowledge and decision-making by health professionals and patients.
In Medicine, knowledge is updated all the time and for this reason a new Clinical Practice Guideline for the treatment and diagnosis of adult patients with type 2 diabetes. This is a highly relevant document that all health professionals should know due to the current national and global panorama.
Current national panorama
In Mexico, glycemic control of people living with diabetes is far from optimal. In 2020, it was reported that only 39% of patients with the disease were within their therapeutic goals. Likewise, the prevalence of obesity in adults in the country is 36.9%one of the risk factors for developing the condition.
“Therefore, it is very important to implement diagnostic and therapeutic strategies based on the best scientific evidence available to optimize early detection, increase the proportion of patients with adequate control of the disease and reduce the risk of associated complications and premature mortality,” said Doctor Nikos Secchi, former president of the College of Internal Medicine of Mexico (CMIM).
Taking into account this reality, where diabetes does not manifest itself, the College of Internal Medicine of Mexico (CMIM), the Mexican Society of Nutrition and Endocrinology (SMNE), the Mexican Society of Cardiology (SMC), the Mexican Institute of Nephrological Research (IMIN), the Mexican Association for the Prevention of Atherosclerosis (AMPAC), the National Regulatory Committee of General Medicine (CONAMEGE), the National College of Geriatric Medicine, the Mexican Academy of Neurology (AMN), the National Association of Cardiologists of Mexico (ANCAM), the Mexican Society of Angiology, Cardiovascular and Endovascular Surgery; With advice from the Ibero-American Agency for the Development and Evaluation of Health Technologies (A2DAHT), they published the “Mexican Clinical Practice Guide for the diagnosis and treatment of adult patients with type 2 diabetes,” which is available in the Mexican Journal of Endocrinology, Metabolism. and Nutrition.
The guideline development group took on the task of reviewing and evaluating all current scientific evidence for diabetes care, comprehensively considering the person who lives with it based on evidence for glucose control. , weight loss, age, life expectancy and the risk of hypoglycemia to recommend the best treatment that achieves a reduction in comorbidities, cardiovascular and renal complications, through the use of disease-modifying therapies.
“Today, clinical studies of new disease-modifying treatments with a comprehensive approach to diabetes control (glucose and weight); They already include Mexican patients, which opens the way for these innovative therapies to be in the process of being available to those with diabetes and obesity in Mexico.”
It is for this reason that clinical practice guidelines require a very well-established protocol for their development and that, to the best available evidence, the best clinical experience is incorporated and that also includes the points of view of the end users, among them. that patients and their caregivers, administrators, family doctors, health policy makers, as well as any organization that develops in the field of medical care must be considered.
“The purpose of this Guide is to contribute to better clinical decision-making and to position it as a reference document in Mexico to generate greater quality in the clinical care of people living with diabetes and that their health and living conditions “are more positive about the disease.”
He explained that the purpose of the joint work was to develop a multi-collaborative document to provide recommendations agreed upon by an interdisciplinary group of experts on the subject, who adhered to international quality standards, such as those described by the US Institute of Medicine. the Institute of Clinical Excellence of Great Britain, the Collegiate Network for the Development of Guidelines of Scotland and the International Network of Clinical Practice Guidelines and thus comply with the required methodology.
The publication of this Guide is a sign of the commitment that the College of Internal Medicine of Mexico (CMIM), the Mexican Society of Nutrition and Endocrinology (SMNE), the Mexican Society of Cardiology (SMC), the Mexican Institute of Nephrological Research (IMIN) , the Mexican Association for the Prevention of Atherosclerosis (AMPAC), the National Normative Committee of General Medicine (CONAMEGE), the National College of Geriatric Medicine, the Mexican Academy of Neurology (AMN), the National Association of Cardiologists of Mexico (ANCAM ) and the Mexican Society of Angiology, Cardiovascular and Endovascular Surgery have and will have to promote continuing medical education and scientific updating to obtain the greatest benefit from innovation focused on the well-being of those living with diabetes in this country.
Figures and data about diabetes and obesity
One in 10 people in the world lives with diabetes. In total there are 536 million people who suffer from this disease. The number of deaths attributable to diabetes reached 6.7 million people in 2021.
Diabetes and obesity in Mexico
12.4 million people live with diabetes. 20.1% of Mexican women over 20 years of age and 16.3% of Mexican men over 20 years of age live with diabetes. 90% of cases of type 2 diabetes mellitus are attributable to obesity. Currently this disease is the leading cause of death among the Mexican population. 36.9% of the population is obese, 41% of Mexican women and 32.3% of Mexican men are obese.
Also read:
CENETEC replaces the Clinical Practice Guidelines for diabetes and apnea
Guide for controlling diabetes with insulin would change for this reason
[Descarga] First medical guide on the use of technology for diabetes care
#Clinical #Practice #Guideline #type #diabetes